Bio-integrated scaffold facilitates large bone regeneration dominated by endochondral ossification

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Large bone defect repair is challenging due to limited regeneration.
• Current treatments for endochondral ossification (ECO) are often unstable and costly.
• Existing methods may require high-dose growth factors or complex cell therapies with side effects.

Purpose of the Study:

• To develop a bio-integrated scaffold for enhanced ECO-dominated bone repair.
• To create a hypoxia microenvironment and control the release of low-dose bone morphogenetic protein-2 (rhBMP-2).
• To improve healing efficiency and reduce risks associated with current bone regeneration strategies.

Main Methods:

• Utilized a mesoporous structure for accelerated iron chelation and deferoxamine (DFO)-induced hypoxia-inducible factor-1α (HIF-1α) to promote chondrogenesis.
• Engineered click-crosslinked PEGylated Poly (glycerol sebacate) (PEGS) layers for programmed release of low-dose rhBMP-2.
• Tested the scaffold's efficacy in large bone defect models, assessing the shift towards ECO-dominated healing.

Main Results:

• The bio-integrated scaffold successfully initiated an early hypoxia microenvironment.
• Controlled release of low-dose rhBMP-2 facilitated cartilage-to-bone transformation with reduced side effects.
• The system demonstrated strengthened ECO healing, converting mixed or intramembranous ossification (IMO) routes to ECO-dominated repair in large models.

Conclusions:

• This biomaterial-based strategy effectively drives ECO-dominated healing for large bone defects.
• The developed scaffold offers a promising approach for clinical translation.
• The findings pave the way for improved treatments in bone regeneration.